Forvis Mazars Wealth Advisors’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-3,350
Closed -$261K 433
2024
Q2
$261K Buy
3,350
+257
+8% +$21K 0.01% 366
2024
Q1
$281K Sell
3,093
-146
-5% -$12.1K 0.01% 357
2023
Q4
$250K Sell
3,239
-13
-0.4% -$910 0.01% 354
2023
Q3
$221K Buy
3,252
+256
+9% +$18.6K 0.01% 364
2023
Q2
$243K Sell
2,996
-239
-7% -$19.1K 0.01% 379
2023
Q1
$265K Buy
+3,235
New +$231K 0.01% 356

Other funds holding GEHC

Forvis Mazars Wealth Advisors's GEHC Position: Q3 2024 in Review

Forvis Mazars Wealth Advisors sold out of GE HealthCare (GEHC) in Q3 2024, closing a stake of 3,350 shares — an estimated $261K sold.

Forvis Mazars Wealth Advisors first reported a position in GEHC in Q1 2023 and held it in 6 quarters. The position peaked at $281K in Q1 2024. 1,272 funds tracked by Wall St. Rank hold GEHC as of Q3 2024.

  • Forvis Mazars Wealth Advisors reported no remaining GE HealthCare position as of Q3 2024 after selling out during the quarter.
  • Forvis Mazars Wealth Advisors sold 3,350 GE HealthCare shares in Q3 2024, an estimated $261K.
  • Forvis Mazars Wealth Advisors first reported a position in GE HealthCare in Q1 2023 and held it in 6 quarters.
  • Forvis Mazars Wealth Advisors's GE HealthCare position peaked at $281K in Q1 2024.
  • 1,272 funds tracked by Wall St. Rank held GE HealthCare as of Q3 2024.

Based on Forvis Mazars Wealth Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.